HKB's Mouse Passive Heymann Nephritis Models provide pharmaceutical researchers with robust platforms for investigating membranous nephropathy, a leading cause of nephrotic syndrome in adults. Our validated rodent models utilize anti-Fx1A antibody injection to replicate key features of membranous nephropathy including subepithelial immune complex deposition, podocyte damage, and proteinuria.
HkeyBio is a China-based, globally-focused preclinical CRO dedicated exclusively to autoimmune and allergic diseases, with a unified service network across Asia, the Americas, Europe and Australia.